United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®
Go back to United Therapeutics Announces FDA Approval Of The Implantable System For Remodulin®| Medtronic Inc. (NYSE: MDT) | Delayed: 80.93 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $80.93 | 52 Week High | $89.27 | |||
| Open | $80.93 | 52 Week Low | $71.03 | |||
| Day High | $80.93 | P/E | 22.99 | |||
| Day Low | $80.93 | EPS | $3.52 | |||
| Volume | 500 | |||||
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 544.92 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $544.92 | 52 Week High | $164.04 | |||
| Open | $544.92 | 52 Week Low | $97.52 | |||
| Day High | $544.92 | P/E | 99.62 | |||
| Day Low | $544.92 | EPS | $5.47 | |||
| Volume | 1 | |||||
